Philips PET/MR system
March 8, 2011 – Patient-focused technologies that also foster greater collaboration between radiologists and referring physicians are being highlighted at the 2011 European Congress of Radiology (ECR). At the conference, Philips is introducing Imaging 2.0, which enables enhanced and smarter collaboration through advanced technology with the hope of better patient outcomes and lower costs for the healthcare system.
“Just as Web 2.0 redefined the way people connect, share and use the Internet, Imaging 2.0 represents a new world of possibilities for radiology science,” said Michèle Lesieur, senior vice-president of Philips Imaging Systems. “It is about integration and collaboration, and new levels of patient focus and safety that can help clinicians achieve what was unimaginable just a few short years ago. With Philips, the radiologist can now integrate information from various sources to make a confident diagnosis and discuss it with all the clinical partners on the case - putting the radiologist at the center of clinical decision-making. This kind of collaboration and integration, combined with major advancements in patient safety and comfort, all packaged to provide an excellent economic advantage for the radiologist, has triggered the next revolution in imaging: Imaging 2.0.”
In addition, the company is showcasing several other new technologies:
• Ingenuity TF PET/MR: Philips recently received CE marking for the industry’s first commercially available whole-body PET/MR imaging system, the Ingenuity TF PET/MR. This new system integrates the molecular imaging capabilities of positron emission tomography (PET) with the superior soft tissue contrast of magnetic resonance (MR). The system can also acquire separate PET and MR images. It is not available in the United States.
• Ingenuity CT: This is a new computed tomography (CT) platform that offers up to 80 percent less dose while maintaining diagnostic image quality and improving spatial resolution. The system is designed to provide equivalent diagnostic image quality with the same look as full-dose images at a fraction of the dose.
• Ingenuity TF PET/CT: This is a premium hybrid imaging system combining PET and CT to conduct studies in oncology imaging, cardiac perfusion and diagnostic CT. The Ingenuity TF PET/CT system includes all of the benefits of the Ingenuity CT platform, including dose-reduction technologies.
• Philips Ingenia: The first digital broadband magnetic resonance imaging (MRI) solution delivers image clarity, scanning efficiency and scalability. It is not available in the United States.
• IntelliSpace Portal: A new multi-modality, multi-vendor workstation uses advanced networking capabilities to facilitate collaboration between radiologists and referring clinicians anytime, regardless of modality or vendor. This ultimately helps to speed clinical diagnosis.
• iU22 xMatrix Ultrasound: A new ultrasound system allows clinicians to create two full-resolution images simultaneously, capturing twice as much clinical information in the same amount of time without moving, turning or rotating the transducer.
• MobileDiagnost wDR: This system will be shown as a work-in-progress. It is being designed to offer the quality and efficiency of a premium digital radiography (DR) suite packed into a flexible mobile X-ray system. It is being developed with the same wireless portable detector, user interface and image processing that are already in use.
• Philips Media Distribution Center (MDC) Enterprise PACS R2.3: Philips is showing a new picture archiving and communication system (PACS) specifically designed to meet the needs of markets and segments that require a scalable value proposition. It facilitates the dissemination of diagnostic imaging beyond the radiology department, enabling Web-based access both throughout the hospital and remotely. The system delivers an easy-to-use, simple-to-install image management system, which is flexible and less costly to purchase and run than conventional PACS. Initially, it will not be available in the United States.
• Sonalleve MR-HIFU: New therapy applications are available with this platform, specifically for the palliative pain treatment of bone metastases. It was initially launched to offer a noninvasive alternative to traditional surgical treatments for uterine fibroids in women. It combines magnetic resonance imaging with high-intensity focused ultrasound (HIFU) therapy. It is not available in the United States.
For more information: www.philips.com
March 26, 2026 
